MA-Balb Cells

Unit

3 x 10^6 cells/ml

Cell Type

Tumor Cells

Tissue Type

Mouse cell lines

Organism

Mouse

Donor History

Malignant neoplasms of the mouse mammary gland

Growth Properties

Adherent

Growth Conditions

Culture medium: DMEM

,

w: 4.5 g/L Glucose

,

w: 4 mM L-Glutamine

,

w: 3.7 g/L NaHCO3

,

w: 1.0 mM Sodium pyruvate (Cytion article number 820300a). Supplements: Supplement the medium with 10% FBS. Dissociation reagent: Accutase. Freeze medium: As a cryopreservation medium

,

we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability

,

or CM-1 (Cytion catalog number 800100)

,

which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C

,

5% CO2

,

humidified atmosphere.

Immortalization Method
Full Information

https://www.cytion.com/MA-Balb-Cells/400270

SKU: 400270 Kategorie: ,
Mgr. Otakar Fišer
Máte otázky k tomuto produktu? Kontaktujte našeho specialistu.
Mgr. Otakar Fišer
Produktový manažer - Life Science
Popis

Ma-Balb is a mouse cell line established in vitro from a solid, spontaneously occurring mammary carcinoma in a female BALB/c mouse. This cell line originated from a solid, bean-sized tumor obtained from the mammary region of a young BALB/c mouse. Ma-Balb cells are significant in cancer research, particularly for studying mammary tumors, due to their derivation from a tumor-prone strain known for developing such cancers.

The Ma-Balb cell line, with its fibroblast-like morphology, provides a robust model for investigating the cellular and molecular mechanisms driving mammary carcinoma. Researchers utilize these cells to explore the genetic and environmental factors that contribute to tumorigenesis, enabling a deeper understanding of cancer biology. Furthermore, Ma-Balb cells are instrumental in testing new anticancer treatments, offering insights into drug efficacy and toxicity. Their relevance extends to immunological studies, where they help elucidate the interactions between cancer cells and the immune system, thereby contributing to the advancement of immunotherapies.

O značce

Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.

Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.